237 related articles for article (PubMed ID: 34605891)
21. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study.
van Gelder BM; Tijhuis M; Kalmijn S; Kromhout D
Am J Clin Nutr; 2007 Apr; 85(4):1142-7. PubMed ID: 17413117
[TBL] [Abstract][Full Text] [Related]
22. Association of reported fish intake and supplementation status with the omega-3 index.
Jackson KH; Polreis JM; Tintle NL; Kris-Etherton PM; Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2019 Mar; 142():4-10. PubMed ID: 30773210
[TBL] [Abstract][Full Text] [Related]
23. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
[TBL] [Abstract][Full Text] [Related]
24. Cross-sectional study of the combined associations of dietary and supplemental eicosapentaenoic acid + docosahexaenoic acid on Omega-3 Index.
McDonnell SL; French CB; Baggerly CA; Harris WS
Nutr Res; 2019 Nov; 71():43-55. PubMed ID: 31757628
[TBL] [Abstract][Full Text] [Related]
25. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review.
Andriambelo B; Stiffel M; Roke K; Plourde M
Ageing Res Rev; 2023 Mar; 85():101835. PubMed ID: 36603691
[TBL] [Abstract][Full Text] [Related]
26. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.
Miller PE; Van Elswyk M; Alexander DD
Am J Hypertens; 2014 Jul; 27(7):885-96. PubMed ID: 24610882
[TBL] [Abstract][Full Text] [Related]
27. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
28. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease.
Wood AHR; Chappell HF; Zulyniak MA
Eur J Nutr; 2022 Mar; 61(2):589-604. PubMed ID: 34392394
[TBL] [Abstract][Full Text] [Related]
29. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
30. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
Cederholm T; Palmblad J
Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
[TBL] [Abstract][Full Text] [Related]
31. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW
BMC Med; 2024 Mar; 22(1):109. PubMed ID: 38468309
[TBL] [Abstract][Full Text] [Related]
32. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
Young GS; Conquer JA; Thomas R
Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis.
Wu S; Ding Y; Wu F; Li R; Hou J; Mao P
Neurosci Biobehav Rev; 2015 Jan; 48():1-9. PubMed ID: 25446949
[TBL] [Abstract][Full Text] [Related]
34. Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.
Dacks PA; Shineman DW; Fillit HM
J Nutr Health Aging; 2013 Mar; 17(3):240-51. PubMed ID: 23459977
[TBL] [Abstract][Full Text] [Related]
35. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
[TBL] [Abstract][Full Text] [Related]
36. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
[TBL] [Abstract][Full Text] [Related]
37. Dietary fatty acids and risk of Alzheimer's disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP).
Gustafson DR; Bäckman K; Scarmeas N; Stern Y; Manly JJ; Mayeux R; Gu Y
Alzheimers Dement; 2020 Dec; 16(12):1638-1649. PubMed ID: 32715635
[TBL] [Abstract][Full Text] [Related]
38. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
[TBL] [Abstract][Full Text] [Related]
39. The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials.
AbuMweis S; Abu Omran D; Al-Shami I; Jew S
Complement Ther Med; 2021 Mar; 57():102662. PubMed ID: 33418065
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
Marik PE; Varon J
Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
